CAR-T Therapy for Cancer Under Scrutiny: Potential Risks

At least for now, in the field of hematologic malignancies, CAR-T has demonstrated very strong efficacy and a favorable benefit-risk ratio, which is why CAR-T therapy is popular.

Related Article